Figures computed from official regulatory filings — .
Analysttarget 11.75 USD (+126%) · consensus 4.75/5 · 4 buy · 0 hold · 0 sell
Ownershipinsiders 12.34% · institutions 34.55% · short 0.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for PolyPid Ltd. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Hazan Dalit Fellous | AwardD (derivative) | $334.5K | SEC |
| Missulawin Jonathan | AwardD (derivative) | $218.5K | SEC |
| Barenholz Yechezkel | AwardD (derivative) | $40.7K | SEC |
| BenAmram Joseph | AwardD (derivative) | $40.7K | SEC |
| Stein Robert Benjamin | AwardD (derivative) | $40.7K | SEC |
| Dror-Darwish Nir | AwardD (derivative) | $40.7K | SEC |
| Warshavsky Ori | AwardD (derivative) | $205.2K | SEC |
| Story Brooke | AwardD (derivative) | $40.7K | SEC |
| Krinsky Itzhak | AwardD (derivative) | $40.7K | SEC |
| Akselbrad Dikla Czaczkes | AwardD (derivative) | $664.5K | SEC |